REGISTERED
on 26 Jan 2021
Last Applicant/ Owned by
61118 Bad Vilbel
DE
Serial Number
79279095 filed on 18th Dec 2019
Registration Number
6253560 registered on 26th Jan 2021
Correspondent Address
Charles T. J. Weigell
Filing Basis
No Filing Basis
Disclaimer
NO DATA
XIMLUCI
Pharmaceutical preparations and biologic medicines used in the treatment of angiogenesis and ocular diseases and disorders as well as angiogenesis and ocular conditions related to diabetic, oncological, macular and vascular diseases and disorders; dietetic food adapted for medical use; dietary supplements for humans The wording "XIMLUCI" has no meaning in a foreign language. Applicators in the n Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations and biologic medicines used in the treatment of angiogenesis and ocular diseases and disorders as well as angiogenesis and ocular conditions related to diabetic, oncological, macular and vascular diseases and disorders; dietetic food adapted for medical use; dietary supplements for humans
Class [010]
Medical Instrument Products
Applicators in the nature of droppers sold empty and syringes for administering medications into the human eye; medical apparatus for introducing pharmaceutical preparations into the human body; diagnostic apparatus for detecting angiogenesis and ocular diseases and disorders
Mark Details
Serial Number
No 79279095
Mark Type
No Service/Collective Mark
Attorney Docket Number
No SAZ 2004718
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 04th Jun 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| 23rd May 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 29th Apr 2021 | FINAL DISPOSITION PROCESSED |
| 29th Apr 2021 | FINAL DISPOSITION NOTICE SENT TO IB |
| 26th Apr 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 26th Jan 2021 | REGISTERED-PRINCIPAL REGISTER |
| 10th Nov 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 10th Nov 2020 | PUBLISHED FOR OPPOSITION |
| 08th Nov 2020 | NOTIFICATION PROCESSED BY IB |
| 21st Oct 2020 | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED |